The mark consists of the letter "CO" in large capital letters shaded in red and outlined in black followed by the word "Fix" in white and outlined in black with the letters "RX" dropped after the letter "x" in "Fix" with the letter "R" in red and a portion of the letter "X" in white both of which are outlined in black.
Mark For: COFIX RX™ trademark registration is intended to cover the categories of
>The color(s) red, black and white is/are claimed as a feature of the mark. The mark consists of the letter "CO" in large capital letters shaded in red and outlined in black followed by the word "Fix" in white and outlined in black with the letters "RX" dropped after the letter "x" in "Fix" with the letter "R" in red and a portion of the letter "X" in white both of which are outlined in black.
Research | OneLook Acronym Finder |
Serial Number | 90337951 |
Mark Literal Elements | COFIX RX |
Mark Drawing Type | 5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2022-04-25 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Michael G. Shariff |
Attorney Docket Number | 060645.0004 |
2020-11-23 | Application Filed |
2020-11-26 | Location: NEW APPLICATION PROCESSING |
2020-11-26 | Status: Live/Pending |
2020-11-26 | Transaction Date |
2022-04-25 | Location: PUBLICATION AND ISSUE SECTION |
2022-04-25 | Status: Review prior to publication completed. |
2022-05-31 | Published |
Party: | CoFix-RX, LLC |
Address | 40900 Woodward Avenue Suite 111 Bloomfield Hills, MICHIGAN UNITED STATES 48304 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | MICHIGAN |
Application | 2020-11-23 | |
Drawing | 2020-11-23 | |
summary-SearchSummary202104132254175360400194 | 2021-04-13 | |
Non-Final Action | 2021-04-14 | |
summary-SearchSummary202104141453250060400620 | 2021-04-14 | |
Response to Office Action | 2021-09-09 | |
Amendment and Mail Process Complete | 2021-09-10 | |
Final Action | 2021-10-08 | |
TEAS Request Reconsideration after FOA | 2022-04-06 | |
Amendment and Mail Process Complete | 2022-04-07 | |
TRAM Snapshot of App at Pub for Oppostn | 2022-04-23 |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances, used internally as pills and other solids, and also used as sprays and liquids for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; Pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; All-purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Nasal spray for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, spores
IC 011. US 013 021 023 024 031 034. G & S: Disinfectant apparatus for medical purposes; Disinfectant apparatus for medical purposes for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Cleansing/sanitizing system comprising a containment enclosure specially adapted for containing an atomized cleansing/sanitizing spray mechanism for use in the cleansing/sanitizing of objects including articles of manufacture, natural products, foods and pharmaceuticals
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 11 |
U.S. Codes: | 013,021,023,024,031,034 |
Type Code | Type |
---|---|
DM0000 | The mark consists of letters "C" and "O" adjacent words "Fix" and "Rx". |
Description | Date | Proceeding Number |
---|---|---|
ASSIGNED TO LIE | 2022-04-25 | 70884 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-04-22 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-04-06 | 88889 |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2022-04-06 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-04-06 | 88889 |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2021-10-08 | |
FINAL REFUSAL WRITTEN | 2021-10-08 | 72008 |
FINAL REFUSAL E-MAILED | 2021-10-08 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-09-09 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-09-09 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-09-09 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-04-14 | |
NON-FINAL ACTION WRITTEN | 2021-04-14 | 72008 |
NON-FINAL ACTION E-MAILED | 2021-04-14 | |
ASSIGNED TO EXAMINER | 2021-04-13 | 72008 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-01-28 | |
NEW APPLICATION ENTERED IN TRAM | 2020-11-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.